Variant report
Variant | nsv600045 |
---|---|
Chromosome Location | chr5:151513383-151527831 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:28)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:28 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:151523879..151524822-chr5:151665463..151666473,3 | MCF-7 | breast: | |
2 | chr5:151513919..151516215-chr5:151517657..151519224,2 | K562 | blood: | |
3 | chr5:151523886..151524850-chr5:151572559..151573494,21 | MCF-7 | breast: | |
4 | chr5:151523874..151524765-chr5:151668143..151669088,3 | MCF-7 | breast: | |
5 | chr5:151523917..151524489-chr5:151572860..151573489,2 | MCF-7 | breast: | |
6 | chr5:151302299..151302849-chr5:151522311..151522997,2 | MCF-7 | breast: | |
7 | chr5:151204736..151205618-chr5:151521905..151522989,3 | MCF-7 | breast: | |
8 | chr5:151523925..151524850-chr5:151572610..151573431,6 | MCF-7 | breast: | |
9 | chr5:151523912..151524811-chr5:151568652..151569394,2 | MCF-7 | breast: | |
10 | chr5:151523242..151525301-chr5:151526406..151528109,3 | MCF-7 | breast: | |
11 | chr5:151522014..151522696-chr5:151729134..151730175,3 | MCF-7 | breast: | |
12 | chr5:151509815..151512281-chr5:151517345..151519719,2 | MCF-7 | breast: | |
13 | chr5:151204677..151205872-chr5:151522532..151523052,3 | MCF-7 | breast: | |
14 | chr5:151513671..151516215-chr5:151517705..151520059,3 | K562 | blood: | |
15 | chr5:151484112..151485634-chr5:151524575..151526562,2 | K562 | blood: | |
16 | chr5:151160169..151163153-chr5:151522448..151524598,2 | K562 | blood: | |
17 | chr5:151522783..151523283-chr8:54673594..54674407,2 | NB4 | blood: | |
18 | chr5:151520907..151523004-chr5:151546531..151548901,2 | K562 | blood: | |
19 | chr5:151513919..151516215-chr5:151517657..151519224,2 | K562 | blood: | |
20 | chr5:151522076..151522840-chr5:151650800..151651429,3 | MCF-7 | breast: | |
21 | chr5:151204595..151205535-chr5:151522142..151523020,2 | K562 | blood: | |
22 | chr5:151524627..151526976-chr5:151527410..151529295,2 | K562 | blood: | |
23 | chr5:151523242..151525301-chr5:151526406..151528109,3 | MCF-7 | breast: | |
24 | chr5:151524627..151526976-chr5:151527410..151529295,2 | K562 | blood: | |
25 | chr5:151513671..151516215-chr5:151517705..151520059,3 | K562 | blood: | |
26 | chr5:151523874..151524433-chr5:151668425..151669088,2 | MCF-7 | breast: | |
27 | chr5:151303110..151303991-chr5:151522441..151523040,2 | MCF-7 | breast: | |
28 | chr5:151303407..151303946-chr5:151522386..151523026,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs549189525 | chr5:151513864-151513865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs567487212 | chr5:151513917-151513918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs141689220 | chr5:151513920-151513921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs190286294 | chr5:151513931-151513932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs146240654 | chr5:151513989-151513990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs538296394 | chr5:151514029-151514030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs556901394 | chr5:151514090-151514091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs29827 | chr5:151514100-151514101 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs542914811 | chr5:151514128-151514129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs29826 | chr5:151514171-151514172 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs573031518 | chr5:151514182-151514183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541515391 | chr5:151514188-151514189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs182821192 | chr5:151514267-151514268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs552136842 | chr5:151514290-151514291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs35976352 | chr5:151514333-151514334 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs200281065 | chr5:151514336-151514337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs115620272 | chr5:151514352-151514353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs545102504 | chr5:151514376-151514377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532029077 | chr5:151514385-151514386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs550210324 | chr5:151514441-151514442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs531126699 | chr5:151514442-151514443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs39804 | chr5:151514484-151514485 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs561149530 | chr5:151514549-151514550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs528707308 | chr5:151514619-151514620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs547162234 | chr5:151514639-151514640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs571287986 | chr5:151514645-151514646 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs186950704 | chr5:151514690-151514691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs115157739 | chr5:151514708-151514709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs568834043 | chr5:151514765-151514766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs29825 | chr5:151514782-151514783 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs554854078 | chr5:151514846-151514847 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs139333984 | chr5:151514874-151514875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs374672292 | chr5:151514895-151514896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs29824 | chr5:151514956-151514957 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs546271701 | chr5:151514958-151514959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs544769960 | chr5:151515030-151515031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs76695863 | chr5:151515031-151515032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs112888550 | chr5:151515056-151515057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs191698817 | chr5:151515084-151515085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs183993324 | chr5:151515099-151515100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs559756317 | chr5:151515107-151515108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs188837998 | chr5:151515124-151515125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs149936801 | chr5:151515199-151515200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs112851297 | chr5:151515201-151515202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs528766749 | chr5:151515255-151515256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs546906353 | chr5:151515260-151515261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs565447951 | chr5:151515332-151515333 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs576557492 | chr5:151515339-151515340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs144105761 | chr5:151515350-151515351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs191157327 | chr5:151515388-151515389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Hyperekplexia | 16941485 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Crohn''s disease | 20877625 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Breast cancer | 17603634 | CNVD |
Crohn''s disease | 20106866 | CNVD |
Breast cancer | 20409316 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Prostate cancer | 18632612 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:151513800-151515000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
2 | chr5:151515000-151518200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
3 | chr5:151516000-151516800 | Enhancers | Fetal Lung | lung |
4 | chr5:151516200-151517200 | Enhancers | Brain Hippocampus Middle | brain |
5 | chr5:151516400-151518600 | Enhancers | Ovary | ovary |
6 | chr5:151516600-151516800 | Bivalent Enhancer | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr5:151516600-151516800 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
8 | chr5:151516600-151518000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
9 | chr5:151517600-151518200 | Bivalent Enhancer | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr5:151518200-151518600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
11 | chr5:151518600-151531200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
12 | chr5:151519400-151520400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
13 | chr5:151521000-151522400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr5:151522000-151522800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
15 | chr5:151522600-151524400 | Enhancers | Stomach Mucosa | stomach |
16 | chr5:151523600-151524800 | Enhancers | Placenta | Placenta |
17 | chr5:151524000-151524800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
18 | chr5:151524600-151525200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
19 | chr5:151524800-151525800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
20 | chr5:151525800-151526000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
21 | chr5:151526000-151527200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
22 | chr5:151526600-151527200 | Enhancers | Fetal Lung | lung |
23 | chr5:151526600-151527200 | Enhancers | Ovary | ovary |
24 | chr5:151527200-151527400 | Active TSS | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |